Moderna and UK government sign deal to establish mRNA facility
Pharmaceutical Technology
DECEMBER 21, 2022
Moderna and the UK government have entered a ten-year strategic collaboration to build a messenger ribonucleic acid (mRNA) research, development and manufacturing facility in the country. Planned to be operational by 2025, the construction of the facility is anticipated to begin early next year. Free Whitepaper.
Let's personalize your content